Anti-ZO1 tight junction protein antibody [EPR19945-296] (Ab221547)
ZO1, TJP1, Tight junction protein 1, Tight junction protein ZO-1, Zona occludens protein 1, Zonula occludens protein 1
用户验证的应用
推荐稀释比例
- IHC-P1/500 Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- ICC/IF1/100
- Flow Cyt (Intra)1/60
详细信息
背景信息
Product Specifications Anti-ZO1 tight junction protein antibody [EPR19945-296] (ab221547) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF, IHC-P in human, mouse, rat samples. Anti-ZO1 tight junction protein antibody [EPR19945-296] (ab221547) specifically detects ZO1 tight junction protein (UniProt ID: Q07157; Molecular weight: 195kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL). Quality and Validation Abcam's high quality manufacturing and validation processes ensure Anti-ZO1 tight junction protein antibody [EPR19945-296] (ab221547) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. Anti-ZO1 tight junction protein antibody [EPR19945-296] (ab221547) has been cited over 75 times in peer reviewed journals and is trusted by the scientific community. Anti-ZO1 tight junction protein antibody [EPR19945-296] (ab221547) has 6 independent reviews from customers. Related Products Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.
文献引用 (183)
Modular assembled biomimetic nanobubbles for synergistic therapy of ischemic stroke via cascade modulation thrombo-inflammatory network.
模块化组装仿生纳米气泡通过级联调节血栓炎症网络协同治疗缺血性中风
Polystyrene nanoplastics disrupt the intestinal microenvironment by altering bacteria-host interactions through extracellular vesicle-delivered microRNAs.
聚苯乙烯纳米塑料通过细胞外囊泡递送的微RNA改变细菌与宿主的相互作用,从而破坏肠道微环境
Repair-associated macrophages increase after early-phase microglia attenuation to promote ischemic stroke recovery
早期小胶质细胞减少后,修复相关巨噬细胞数量增加,从而促进缺血性卒中后的恢复。
Gut microbiota-derived tryptophan metabolites regulated by Wuji Wan to attenuate colitis through AhR signaling activation
戊己丸调节肠道菌群衍生的色氨酸代谢物,通过激活 AhR 信号减轻结肠炎
Peptide-Bound Aflibercept Eye Drops for Treatment of Neovascular Age-Related Macular Degeneration in Nonhuman Primates.
用于治疗非人灵长类动物新生血管性年龄相关性黄斑变性的肽结合阿柏西普滴眼液
Gut microbial dysbiosis exacerbates long-term cognitive impairments by promoting intestinal dysfunction and neuroinflammation following neonatal hypoxia-ischemia
肠道微生物失调会促进新生儿缺氧缺血后的肠道功能障碍和神经炎症,从而加剧长期认知障碍
Amyotrophic lateral sclerosis and frontotemporal dementia mutation reduces endothelial TDP-43 and causes blood-brain barrier defects
肌萎缩侧索硬化症和额颞叶痴呆的基因突变会降低内皮细胞TDP-43的水平,并导致血脑屏障缺陷。
Ultrasound molecular imaging of M2 macrophages for early detection of chronic rejection in heart transplantation
利用超声分子成像技术检测M2巨噬细胞在心脏移植术后慢性排斥反应早期诊断中的应用
Curcumin-loaded milk-derived sEVs fused with platelet membrane attenuate endothelial senescence and promote spinal cord injury recovery in diabetic mice.
负载姜黄素的乳源性小细胞外囊泡与血小板膜融合,可减轻糖尿病小鼠的内皮细胞衰老并促进脊髓损伤的恢复
ITLN1 exacerbates Crohn's colitis by driving ZBP1-dependent PANoptosis in intestinal epithelial cells through antagonizing TRIM8-mediated CAPN2 ubiquitination.
ITLN1 通过拮抗 TRIM8 介导的 CAPN2 泛素化,驱动肠上皮细胞中 ZBP1 依赖的 PANoptosis,从而加剧克罗恩结肠炎
- 1
- 2
- 3
- 4
- 5
- 6
- 19